Paul Koller

32PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyHaematologyHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 24, 2026
CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission.

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

|Sep 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.

Jose Tinajero, Kim Nguyen, Dat Ngo

|Sep 01, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.

Hoda Pourhassan, Jose Tinajero, Huiyan Ma

|Jun 10, 2025
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission.

Jose Tinajero, Dat Ngo, Maria Motta

|Apr 10, 2025
Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T-cell precursor acute lymphoblastic leukaemia.

Vaibhav Agrawal, Shukaib Arslan, Hoda Pourhassan

Pageof 6

Frequent Collaborators

20 joint publications

Ibrahim Aldoss

15 joint publications

Monzr M Al-Malki

12 joint publications

Amandeep Salhotra

12 joint publications

Ryotaro Nakamura